Format

Send to:

Choose Destination
See comment in PubMed Commons below
Pathog Glob Health. 2012 Sep;106(5):286-98. doi: 10.1179/2047773212Y.0000000048.

Immunological and molecular diagnosis of cysticercosis.

Author information

  • 1Infectious Diseases, Instituto Nacional de Ciencias Neurol√≥gicas, Jr. Anchash 1271, Lima 1, Peru. silvia@peruresearch.org

Abstract

Cysticercosis, the infection with the larval stage of Taenia solium, is a cause of neurological symptoms including seizures, affecting the quality of life of patients and their families. Diagnosis focuses on brain imaging and serological tests are mostly used as confirmatory tools. Most cases, however, occur in poor endemic areas, where both kinds of diagnostic tools are poorly available. Development of point of care diagnostic tests is one of the most important priorities for cysticercosis researches today. The ideal point of care test would require detection of viable cysticercosis and hopefully identify cases with severe or progressive forms of neurocysticercosis, leading to referral of the patient for specialized medical attention. This manuscript describes the evolution of the serological diagnosis of cysticercosis over time, and the characteristics of the most common currently available tools, their advantages and disadvantages, and their potential use in future diagnostic tests.

PMID:
23265553
[PubMed - indexed for MEDLINE]
PMCID:
PMC4005112
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon Icon for PubMed Central
    Loading ...
    Write to the Help Desk